Boston Private Bank & Trust’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$26.2M Sell
378,120
-7,660
-2% -$529K 1.21% 14
2014
Q4
$26.7M Sell
385,780
-6,497
-2% -$439K 1.24% 14
2014
Q3
$25.6M Sell
392,277
-32,334
-8% -$2.13M 1.25% 17
2014
Q2
$28.9M Sell
424,611
-13,059
-3% -$875K 1.4% 10
2014
Q1
$28.4M Sell
437,670
-8,058
-2% -$508K 1.44% 8
2013
Q4
$29.1M Sell
445,728
-14,021
-3% -$897K 1.45% 5
2013
Q3
$27.3M Sell
459,749
-4,431
-1% -$263K 1.51% 5
2013
Q2
$26.6M Buy
+464,180
New +$27.6M 1.55% 6

Other funds holding CL

Boston Private Bank & Trust's CL Position: Q1 2015 in Review

Boston Private Bank & Trust reduced its Colgate-Palmolive (CL) stake by 2% in Q1 2015, selling an estimated $529K and leaving 378,120 shares worth $26.2M. The position accounts for 1.21% of the portfolio, ranked #14.

Boston Private Bank & Trust first reported a position in CL in Q2 2013 and has held it in 8 quarters since. The position peaked at $29.1M in Q4 2013. 1,226 funds tracked by Wall St. Rank hold CL as of Q1 2015.

  • Boston Private Bank & Trust held 378,120 shares of Colgate-Palmolive worth $26.2M as of Q1 2015.
  • Boston Private Bank & Trust sold 7,660 Colgate-Palmolive shares in Q1 2015, an estimated $529K.
  • Colgate-Palmolive made up 1.21% of Boston Private Bank & Trust's portfolio in Q1 2015, its #14 holding.
  • Boston Private Bank & Trust first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 8 quarters since.
  • Boston Private Bank & Trust's Colgate-Palmolive position peaked at $29.1M in Q4 2013.
  • 1,226 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.